Medy-Tox Inc. (086900.KQ) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	251.1B	247.3B	228.6B	221.1B	195.1B
Cost of Revenue	101.2B	110.6B	89.6B	87.2B	71.0B
Gross Profit	149.9B	136.7B	139.0B	133.9B	124.1B
Operating Expenses
R&D Expense	29.2B	29.2B	29.8B	25.1B	23.3B
SG&A Expense	37.9B	62.4B	54.6B	61.4B	52.5B
General & Admin Expense	(22.2B)	2.4B	2.4B	2.3B	1.9B
Selling & Marketing Expense	60.1B	60.1B	52.2B	59.1B	22.0B
Other Expenses	65.5B	28.4B	34.3B	30.0B	1.8B
Total Operating Expenses	132.6B	120.1B	118.7B	116.5B	77.7B
Cost and Expenses	233.5B	230.1B	208.3B	203.8B	148.7B
Operating Income (EBIT)	17.3B	16.6B	20.3B	17.3B	46.4B
Non-Operating
Interest Income	4.9B	1.4B	925.2M	896.4M	610.8M
Interest Expense	(1.9B)	649.4M	1.7B	2.3B	2.3B
Net Interest Income	6.8B	745.8M	(801.7M)	(1.4B)	(1.7B)
Other Non-Op Income/Expense	(9.6B)	—	(2.8B)	(1.5B)	3.1B
Non-Operating Income (excl Interest)	—	—	1.1B	(863.7M)	(8.6B)
EBT (Pre-Tax Income)	7.8B	6.6B	17.5B	15.9B	49.5B
Income Tax Expense	(7.4B)	(9.1B)	1.4B	6.2B	12.9B
Bottom Line
Net Income	15.3B	16.6B	17.0B	9.8B	37.0B
Earnings from Cont. Ops	15.1B	15.7B	16.1B	9.7B	36.6B
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	15.3B	15.6B	16.0B	9.8B	37.0B
Per Share
Basic EPS	₩2,334	₩2,371	₩2,377	₩1,311	₩5,492
Diluted EPS	₩2,334	₩2,371	₩2,377	₩1,311	₩5,489
Revenue Per Share	₩34,169	₩33,885	₩34,001	₩33,018	₩29,731
Shares
Basic Shares Outstanding	7.3M	7.3M	6.7M	6.7M	6.6M
Diluted Shares Outstanding	7.3M	7.3M	6.7M	6.7M	6.6M
Profitability Metrics
EBITDA	36.7B	36.6B	39.2B	32.7B	70.4B
D&A	19.7B	20.0B	20.0B	15.4B	15.3B
EBIT	17.0B	16.6B	19.2B	17.3B	55.1B

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026